http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1457876-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-14
filingDate 1973-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1457876-A
titleOfInvention Alkanolamine derivatives device for use in
abstract Novel 1-amidoaryloxy-3-amidoalkylamino-2-propanol derivatives of the formula: <IMAGE> wherein the symbols have the meanings given in the Patent Claim, for example 1-o-(N-ss-hydroxyethylcarbamoylmethoxy)-phenoxy-3-ssisobutyramidoethylamino-2-propanol, are prepared by reacting an appropriate 2,3-epoxy-1-phenoxypropane or a 3-halogeno-1-phenoxy-2-propanol with an amine HNR<6>-A-NR<7>-XYR<1>. The compounds exert a blocking action on the adrenergic ss-receptors and can be used for the treatment of cardiac disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5034411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5149523-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5043444-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0322389-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5155133-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0322390-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0322389-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0404748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0322390-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905806-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9015793-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9015794-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905795-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0404747-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905794-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9015792-A1
priorityDate 1972-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415717720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31217

Total number of triples: 34.